Augustine SC, Colcher DM, Rutar FJ, Norenberg JP, Vang K. Determination and control of volatilized 131I released in the preparation of 131I tositumomab dosages for radioimmunotherapy. J Am Pharm Assoc; 2003; 43: 646-8.
Carmichael JA, Power BE, Garrett TP, Yazaki PJ, Shively JE, Raubitschek AA, Wu AM, Hudson PJ. The crystal structure of an anti-CEA scFv diabody assembled from T84.66 scFvs inV(L)-to-V-H orientation: Implications for diabody flexibility. Journal of Molecular Biology; 2003, 326(2): 341-351.
Chen SA, Zhang FM, Sherman MA, Kijima I, Cho M, Yuan YC, Toma Y, Osawa Y, Zhou DJ, Eng ET. Structure-function studies of aromatase and its inhibitors: a progress report. Journal of Steroid Biochemistry and Molecular Biology; 2003, 86(3-5): 231-237.
Cooper LJ, Topp MS, Serrano LM, Gonzalez S, Chang WC, Naranjo A, Wright C, Popplewell L, Raubitschek A, Forman SJ, Jensen MC. T-cell clones can be rendered specific for CD19: toward the selective augmentation of the graft-versus-B-lineage leukemia effect. Blood; 2003, 101(4): 1637-1644.
Espenschied J, Lamont J, Longmate J, Pendas S, Wang Z, Diamond DJ, Ellenhorn JD. CTLA-4 blockade enhances the therapeutic effect of an attenuated poxvirus vaccine targeting p53 in an established murine tumor model. J Immunol; 2003, 170(6): 3401-7.
Jensen MC, Cooper LJ, Wu AM, Forman SJ, Raubitschek A. Immunobiology of engineered CD20-specific primary human cytotoxic T lymphocytes for targeting B-cell malignancy. Cytotherapy; 2003; 5: 131-138.
Keire DA, Wu SV, Diehl DL, Chew P, Ho FJ, Davis MT, Lee TD, Shively JE, Walsh JH, Reeve JR. Rat progastrin processing yields peptides with altered potency at the CCK-B receptor. Regulatory Peptides; 2003, 113(1-3): 115-124.
Wright CL, Naranjo A, Vishwanath RP, Chang WC, Olivares S, Wagner JR, Bruins L, Raubitschek A, Cooper LJ, Jensen MC. Biophotonic cytotoxicity assay for high-throughput screening of cytolytic killing. Journal Of Immunological Methods; 2005, 297(1-2): 39-52.
Chauhan SC, Jain M, Moore ED, Wittel UA, Li J, Gwilt PR, Colcher D, Batra SK. Pharmacokinetics and biodistribution of Lu-177-labeled multivalent single-chain Fv construct of the pancarcinoma monoclonal antibody CC49. European Journal Of Nuclear Medicine And Molecular Imaging; 2005, 32(3): 264-273.
Chen X, Wong P, Radany E, Wong JY. Low doses of HDAC inhibitors enhance radiation-induced apoptosis and modulate mitochondrial localization of Bcl-2 family-proteins in prostate cancer cells. International Journal Of Radiation Oncology Biology Physics; 2005, 63(2): S481-S482.
Chen YJ, Liu A, Tsai PT, Vora NL, Pezner RD, Schultheiss TE, Wong JY. Organ sparing by conformal avoidance intensity-modulated radiation therapy for anal cancer: Dosimetric evaluation of coverage of pelvis and inguinal/femoral nodes. International Journal Of Radiation Oncology Biology Physics; 2005, 63(1): 274-281.
Chen YJ, Liu A, Tsai PT, Vora NL, Pezner RD, Schultheiss TE, Wong JY. Organ sparing by conformal avoidance intensity modulated radiation therapy for anal cancer: Dosimetric evaluation of coverage of pelvis and inguinal/femoral nodes. Journal Of Clinical Oncology; 2005, 23(16): 371S-371S.
Cooper LJ, Al KZ, Serrano LM, Pfeiffer T, Olivares S, Castro A, Chang WC, Gonzalez S, Smith D, Forman SJ, Jensen MC. Enhanced antilymphoma efficacy of CD19-redirected influenza MP1-specific CTLs by cotransfer of T cells modified to present influenza MP1. Blood; 2005, 105(4): 1622-1631.
Crow DM, Williams L, Colcher D, Wong JY, Raubitschek A, Shively JE. Combined Radioimmunotherapy and chemotherapy of breast tumors with Y-90-labeled anti-Her2 and anti-CEA antibodies with Taxol. Bioconjugate Chemistry; 2005, 16(5): 1117-1125.
Ellenhorn JD, Smith DD, Schwarz RE, Kawachi MH, Wilson TG, McGonigle KF, Wagman LD, Paz IB. Paint-only is equivalent to scrub-and-paint in preoperative preparation of abdominal surgery sites. Journal Of The American College Of Surgeons; 2005, 201(5): 737-741.
Gibson G, Daftarian P, Song GY, Diamond DJ, Ellenhorn J. Synergistic effect of an anti-CD25 antibody on MVAp53 treated mice. Annals Of Surgical Oncology; 2005, 12(2): S42-S42.
Gillies SD, Lan Y, Williams S, Carr F, Forman S, Raubitschek A, Lo KM. An anti-CD20-IL-2 immunocytokine is highly efficacious in a SCID mouse model of established human B lymphoma. Blood; 2005, 105(10): 3972-3978.
Gonzalez S, Castanotto D, Li HT, Olivares S, Jensen MC, Forman SJ, Rossi JJ, Cooper LJ. Amplification of RNAi - Targeting HLA mRNAs. Molecular Therapy; 2005, 11(5): 811-818.
Hockaday DC, Shen S, Fiveash J, Raubitschek A, Colcher D, Liu A, Alvarez V, Mamelak AN. Imaging glioma extent with I-131-TM-601. Journal Of Nuclear Medicine; 2005, 46(4): 580-586.
Jain M, Chauhan SC, Singh AP, Venkatraman G, Colcher D, Batra SK. Penetratin improves tumor retention of single-chain antibodies: A novel step toward optimization of radioimmunotherapy of solid tumors. Cancer Research; 2005, 65(17): 7840-7846.
Jensen M. Strategies to enhance the therapeutic efficacy of autologous hematopoietic by posttransplantation stem cell transplantation adoptive transfer of T cells with engineered graft-versus-tumor activity. Biology Of Blood And Marrow Transplantation; 2005, 11(2): 34-39.
Kenanova V, Olafsen T, Crow DM, Sundaresan G, Subbarayan M, Carter NH, Ikle DN, Yazaki PJ, Chatziioannou AF, Gambhir SS, Williams LE, Shively JE, Colcher D, Raubitschek AA, Wu AM. Tailoring the pharmacokinetics and positron emission tomography imaging properties of anti-carcinoembryonic antigen single-chain Fv-Fc antibody fragments. Cancer Research; 2005, 65(2): 622-631.
Krishnan A, Nademanee A, Forman SJ, Fung H, Molina A, Yamauchi D, Spielberger RT, Kogut NM, Raubitschek A. The safety and efficacy of standard-dose Y-90 ibritumomab tiuxetan combined with high-dose BEAM and autologous stem-cell transplantation in patients, including those over 60 years, with non-Hodgkin's lymphoma. International Journal Of Radiation Oncology Biology Physics; 2005, 63(2): S419-S420.
Krishnan AY, Nademanee A, Forman SJ, Fung H, Molina A, Yamauchi D, Spielberger R, Kogut N, Raubitschek A. The outcome of ZBEAM, a regimen combining 90Y ibritumomab tiuxetan with high dose chemotherapy in elderly patients with non-Hodgkin's lymphoma (NHL). Journal Of Clinical Oncology; 2005, 23(16): 576S-576S.
Liu A, Pezner RD, Han C, Schultheiss TE, Wong JY. Dosimetric comparison of helical TomoTherapy treatment and step-and-shoot intensity-modulated radiotherapy treatment on retroperitoneal sarcoma. International Journal Of Radiation Oncology Biology Physics; 2005, 63(2): S454-S454.
Nademanee A, Forman S, Molina A, Fung H, Smith D, Dagis A, Kwok C, Yamauchi D, Anderson AL, Falk P, Krishnan A, Kirschbaum M, Kogut N, Nakamura R, O'Donnell M, Parker P, Popplewell L, Pullarkat V, Rodriguez R, Sahebi F, Smith E, Snyder D, Stein A, Spielberger R, Zain J, White C, Raubitschek A. A phase 1/2 trial of high-dose yttrium-90-ibritumomab tiuxetan in combination with high-dose etoposide and cyclophosphamide followed by autologous stem cell transplantation in patients with poor-risk or relapsed non-Hodgkin lymphoma. Blood; 2005, 106(8): 2896-2902.
Nagata S, Ise T, Onda M, Nakamura K, Ho M, Raubitschek A, Pastan H. Cell membrane-specific epitopes on CD30: Potentially superior targets for immunotherapy. Proceedings Of The National Academy Of Sciences Of The United States Of America; 2005, 102(22): 7946-7951.
Olafsen T, Kenanova VE, Sundaresan G, Anderson AL, Crow D, Yazaki PJ, Li L, Press MF, Williams LE, Wong JY, Raubitschek AA, Shively JE, Wu AM. Optimizing radiolabeled engineered anti-p185(HER2) antibody fragments for in vivo imaging. Cancer Research; 2005, 65(13): 5907-5916.
Pameijer CR, Smith D, McCahill LE, Bimston DN, Wagman LD, Ellenhorn JD. Full-thickness chest wall resection for recurrent breast carcinoma: An institutional review and meta-analysis. American Surgeon; 2005, 71(9): 711-715.
Pantelic M, Kim YJ, Bolland S, Chen I, Shively J, Chen T. Neisseria gonorrhoeae kills carcinoembryonic antigen-related cellular adhesion molecule 1 (CD66a)-expressing human B cells and inhibits antibody production. Infection And Immunity; 2005, 73(7): 4171-4179.
Podnos YD, Smith D, Wagman LD, Ellenhorn JD. Survival in patients with papillary thyroid cancer is not affected by the use of radioactive isotope. Annals Of Surgical Oncology; 2005, 12(2): S21-S21.
Sampath S, Schultheiss TE, Wong J. Dose response and factors related to interstitial pneumonitis after bone marrow transplant. International Journal Of Radiation Oncology Biology Physics; 2005, 63(3): 876-884.
Santat L, Paz H, Wong C, Li LJ, Macer J, Forman S, Wong KK, Chatterjee S. Recombinant AAV2 transduction of primitive human hematopoietic stem cells capable of serial engraftment in immune-deficient mice. Proceedings Of The National Academy Of Sciences Of The United States Of America; 2005, 102(31): 11053-11058.
Schnell R, Dietlein M, Staak JO, Borchmann P, Schomaecker K, Fischer T, Eschner W, Hansen H, Morschhauser F, Schicha H, Diehl V, Raubitschek A, Engert A. Treatment of refractory Hodgkin's lymphoma patients with an iodine-131-labeled murine anti-CD30 monoclonal antibody. Journal Of Clinical Oncology; 2005, 23(21): 4669-4678.
Vishwanath RP, Brown CE, Wagner JR, Meechoovet HB, Naranjo A, Wright CL, Olivares S, Cooper LJ, Jensen MC. A quantitative high-throughput chemotaxis assay using bioluminescent reporter cells. Journal Of Immunological Methods; 2005, 302(1-2): 78-89.
Wang TL, Tamae D, LeBon T, Shively JE, Yen Y, Li JJ. The role of peroxiredoxin II in radation-resistant MCF-7 breast cancer cells. Cancer Research; 2005, 65(22): 10338-10346.
Wilczynski SP, Chen YY, Chen W, Howell SB, Shively JE, Alberts DS. Expression and mutational analysis of tyrosine kinase receptors c-kit, PDGFR alpha, and PDGFR beta in ovarian cancers. Human Pathology; 2005, 36(3): 242-249.
Wittel UA, Jain M, Goel A, Baranowska KJ, Kurizaki T, Chauhan SC, Agrawal DK, Colcher D, Batra SK. Engineering and characterization of a divalent single-chain Fv angiotensin II fusion construct of the monoclonal antibody CC49. Biochemical And Biophysical Research Communications; 2005, 329(1): 168-176.
Wong KK, Chatterjee S. Vaccine development for chronic myelogenous leukaemia. Lancet; 2005, 365(9460): 631-632.
Morris K, Castanotto D, Al KZ, Jensen M, Rossi J, Cooper LJ. Enhancing siRNA effects in T cells for adoptive immunotherapy. Hematology; 2005, 10(6): 461-467.
Podnos YD, Smith D, Wagman LD, Ellenhorn JD. Radioactive iodine offers survival improvement in patients with follicular carcinoma of the thyroid. Surgery; 2005, 138(6): 1072-1076.
Cooper L, Kalos M, DiGiusto D, DiGiusto D, Brown C, Forman S, Raubitschek A, Jensen M. T-cell genetic modification for re-directed tumor recognition. Cancer Chemotherapy & Biological Response Modifiers; 2005; 22: 293-324.
Krymskaya L, Lee WH, Zhong LW, Liu CP. Polarized development of memory cell-like IFN-gamma-producing cells in the absence of TCR zeta-chain. Journal Of Immunology; 2005, 174(3): 1188-1195.
Zhou JH, Hinton DR, Stohlman SA, Liu CP, Zhong LW, Marten NW. Maintenance of CD8(+) T cells during acute viral infection of the central nervous system requires CD4(+) T cells but not interleukin-2. Viral Immunology; 2005, 18(1): 162-169.
